Alex Thompson
Stock Analyst at Stifel
(1.30)
# 2,628
Out of 4,479 analysts
31
Total ratings
39.13%
Success rate
-10.36%
Average return
Main Sectors:
Top Industries:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Buy | $485 → $500 | $435.49 | +14.81% | 4 | Jun 24, 2024 | |
| THRD Third Harmonic Bio | Initiates: Buy | $23 | $12.24 | +87.91% | 1 | Jun 18, 2024 | |
| ASND Ascendis Pharma | Initiates: Buy | $200 | $136.27 | +46.77% | 1 | May 31, 2024 | |
| SYRE Spyre Therapeutics | Reiterates: Buy | $36 → $54 | $23.79 | +126.99% | 2 | Mar 26, 2024 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $44 | $26.27 | +67.49% | 1 | Feb 15, 2024 | |
| VTYX Ventyx Biosciences | Maintains: Hold | $6 → $2 | $2.14 | -6.54% | 5 | Dec 18, 2023 | |
| TVTX Travere Therapeutics | Maintains: Hold | $8 → $10 | $8.09 | +23.61% | 2 | Dec 18, 2023 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Buy | $66 → $69 | $40.15 | +71.86% | 2 | Dec 18, 2023 | |
| ACRS Aclaris Therapeutics | Maintains: Hold | $2 → $1 | $1.14 | -12.28% | 4 | Dec 18, 2023 | |
| MORF Morphic Holding | Maintains: Hold | $61 → $33 | $31.28 | +5.50% | 3 | Sep 25, 2023 | |
| VRDN Viridian Therapeutics | Reiterates: Buy | $40 | $12.16 | +228.95% | 2 | Sep 13, 2023 | |
| RAPT RAPT Therapeutics | Initiates: Buy | $40 | $2.79 | +1,333.69% | 1 | Aug 9, 2023 | |
| IMVT Immunovant | Maintains: Buy | $28 → $34 | $26.52 | +28.21% | 2 | Jul 18, 2023 | |
| PLRX Pliant Therapeutics | Initiates: Buy | $33 | $10.60 | +211.32% | 1 | Dec 14, 2022 |
argenx SE
Jun 24, 2024
Maintains: Buy
Price Target: $485 → $500
Current: $435.49
Upside: +14.81%
Third Harmonic Bio
Jun 18, 2024
Initiates: Buy
Price Target: $23
Current: $12.24
Upside: +87.91%
Ascendis Pharma
May 31, 2024
Initiates: Buy
Price Target: $200
Current: $136.27
Upside: +46.77%
Spyre Therapeutics
Mar 26, 2024
Reiterates: Buy
Price Target: $36 → $54
Current: $23.79
Upside: +126.99%
Dianthus Therapeutics
Feb 15, 2024
Initiates: Buy
Price Target: $44
Current: $26.27
Upside: +67.49%
Ventyx Biosciences
Dec 18, 2023
Maintains: Hold
Price Target: $6 → $2
Current: $2.14
Upside: -6.54%
Travere Therapeutics
Dec 18, 2023
Maintains: Hold
Price Target: $8 → $10
Current: $8.09
Upside: +23.61%
MoonLake Immunotherapeutics
Dec 18, 2023
Maintains: Buy
Price Target: $66 → $69
Current: $40.15
Upside: +71.86%
Aclaris Therapeutics
Dec 18, 2023
Maintains: Hold
Price Target: $2 → $1
Current: $1.14
Upside: -12.28%
Morphic Holding
Sep 25, 2023
Maintains: Hold
Price Target: $61 → $33
Current: $31.28
Upside: +5.50%
Viridian Therapeutics
Sep 13, 2023
Reiterates: Buy
Price Target: $40
Current: $12.16
Upside: +228.95%
RAPT Therapeutics
Aug 9, 2023
Initiates: Buy
Price Target: $40
Current: $2.79
Upside: +1,333.69%
Immunovant
Jul 18, 2023
Maintains: Buy
Price Target: $28 → $34
Current: $26.52
Upside: +28.21%
Pliant Therapeutics
Dec 14, 2022
Initiates: Buy
Price Target: $33
Current: $10.60
Upside: +211.32%